These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1327705)

  • 1. [The erythrocyte sodium and calcium pump activity in hypertensive patients].
    Zhao G
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Feb; 20(1):35-6. PubMed ID: 1327705
    [No Abstract]   [Full Text] [Related]  

  • 2. Transporting of sodium and calcium cation in erythrocyte in patients with essential hypertension.
    Zhu ZM; Song KQ; Liu GY; Li YR
    Chin Med J (Engl); 1990 Feb; 103(2):107-9. PubMed ID: 2167817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile of essential hypertensives based on ion transport abnormalities.
    de la Sierra A; Coca A; Paré JC; Sánchez M; Compte M; Azqueta M; Urbano-Márquez A
    J Hypertens Suppl; 1993 Dec; 11(5):S250-1. PubMed ID: 8158369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activity of transporting ATPase and functional properties of blood cells in patients with hypertension].
    Gurevich VS; Moiseeva OM; Mikhaĭlova IA; Roĭ AIu
    Vopr Med Khim; 1993; 39(1):32-4. PubMed ID: 8388596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte cation transport in obesity, hypertension, and during antihypertensive drug therapy.
    Miilunpalo S; Saarinen R; Marniemi J; Lehtonen A
    Clin Physiol Biochem; 1989; 7(3-4):176-83. PubMed ID: 2572370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
    Maslova MN; Ogorodnikova LE; Titkov IuS
    Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of Ca2(+)-ATPase and calmodulin in erythrocytes and their responses to nifedipine in essential hypertension].
    Song K
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):260-1, 318. PubMed ID: 2150803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanism relating sodium and potassium to hypertension.
    Zhao GS; Li DY; Zhu DL; Kong DW; Qian YW; Li DP
    Ann Clin Res; 1984; 16 Suppl 43():55-61. PubMed ID: 6100156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the structuro-functional properties of erythrocytes in vascular diseases of the brain].
    Mkheian EE; Tunian IuS; Akopov SE; Badzhinian SA; Bakunts GO
    Vopr Med Khim; 1981; 27(4):486-8. PubMed ID: 6270906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The structure and function of the ion transfer ATPases].
    Song LX; Wang RX
    Sheng Li Ke Xue Jin Zhan; 1989 Oct; 20(4):334-8. PubMed ID: 2483758
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intracellular concentrations and transmembrane flow of sodium and potassium in red blood cells of hypertensive patients and their offspring].
    Lijnen P
    Verh K Acad Geneeskd Belg; 1986; 48(4):225-60. PubMed ID: 2431551
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension.
    Fu Y; Wang S; Lu Z; Li H; Li S
    Chin Med J (Engl); 1998 Feb; 111(2):147-9. PubMed ID: 10374376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of red blood cell ion transport alterations and serum lipid abnormalities in Lyon genetically hypertensive rats.
    Zicha J; Dobesová Z; Kunes J; Vincent M
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1123-8. PubMed ID: 9365824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variations in ATPase activities of erythrocytic membrane and endocytic ionic levels in cases with pregnancy induced hypertension].
    Dai LT; Chou SH
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):411-3, 445. PubMed ID: 8001418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte calcium-stimulated, magnesium-activated adenosine 5'-triphosphatase activity in essential hypertension.
    Adeoya AS; Bing RF; Norman RI
    J Hypertens; 1992 Jul; 10(7):651-6. PubMed ID: 1321192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raised sodium pump activity and a circulating sodium transport inhibitor demonstrated on red blood cells of patients with untreated essential hypertension: correlation of pump activity with potassium permeability.
    Skrabal F; Hamberger L; Cerny E; Schönegger J; Gernhold M
    Klin Wochenschr; 1985; 63 Suppl 3():117-21. PubMed ID: 2987607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary salt, intracellular ion homeostasis and hypertension secondary to early-stage kidney disease.
    Schiffl H; Küchle C; Lang S
    Miner Electrolyte Metab; 1996; 22(1-3):178-81. PubMed ID: 8676814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of the sodium-potassium pump and values of sodium and potassium in erythrocytes in patients with non-dialyzed renal failure and arterial hypertension treated conservatively].
    Czarkowski M; Jabłońska-Skwiecińska E; Drygieniec D; Wardyn K; Rojek-Trebicka J; Chodakowska J
    Pol Arch Med Wewn; 1991 Dec; 86(6):341-5. PubMed ID: 1668126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.